Loading…
Loading…
DGX · NYSE · Healthcare
“Quest Diagnostics' defensive healthcare moat and steady earnings warrant consideration, though the 22x multiple demands careful scrutiny against intrinsic value calculations.”
— In the voice of Graham
Track upcoming IPOs for the next three months. Filter by sector and expected valuation range.
Market Cap
$21.72B
P/E Ratio
21.89
Forward P/E
—
EPS
$8.87
PEG Ratio
1.88
Book Value
$64.45
Dividend Yield
1.63%
Profit Margin
8.99%
ROE
13.84%
Use the interactive ipo calendar with pre-loaded data for Quest Diagnostics Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for DGX: